Josip Djelmis1, Mato Pavić2, Vjosa Mulliqi Kotori3, Ivana Pavlić Renar4, Marina Ivanisevic5, Slavko Oreskovic5. 1. School of Medicine, University of Zagreb, Zagreb, Croatia; Department of Obstetrics and Gynecology, Clinical Hospital Center, Zagreb, Croatia. Electronic address: josip.djelmis@zg.t-com.hr. 2. Department of Obstetrics and Gynecology, Clinical Hospital Center, Zagreb, Croatia. 3. Department of Endocrinology, Pediatric Clinic, University Clinical Center, Prishtina, Republic of Kosovo. 4. School of Medicine, University of Zagreb, Zagreb, Croatia; Department of Internal Medicine, Clinical Hospital Center, Zagreb, Croatia. 5. School of Medicine, University of Zagreb, Zagreb, Croatia; Department of Obstetrics and Gynecology, Clinical Hospital Center, Zagreb, Croatia.
Abstract
OBJECTIVE: To investigate the impact of the International Association of Diabetic Pregnancy Study Group (IADPSG) diagnostic criteria on the prevalence of gestational diabetes mellitus (GDM) and overt diabetes as compared with the UK National Institute for Health and Care Excellence (NICE) criteria, and to evaluate the prevalence of maternal and perinatal outcomes among pregnant women with fasting plasma glucose (FPG) levels of 5.1-5.5 mmol/L. METHODS: A retrospective study was undertaken of data for women who underwent a 2-hour 75-g oral glucose tolerance test at 24-32 weeks of a singleton pregnancy at a center in Croatia between January 2012 and December 2014. RESULTS: Among 4646 included women, 1074 (23.1%) had GDM according to IADPSG criteria, 826 (17.8%) would be diagnosed according to NICE criteria, and 50 (1.1%) had overt diabetes. FPG levels were 5.1-5.5 mmol/L for 409 (8.8%) women. Compared with a control group (n=3391), these women had higher odds of large-for-gestational-age newborns (odds ratio 3.7, 95% CI 2.0-4.6) and cesarean delivery (odds ratio 1.8, 95% CI 1.3-2.3). CONCLUSION: Women with FPG levels of 5.1-5.5 mmol/L have an increased risk of adverse maternal and perinatal outcome, although they would not be diagnosed with GDM according to NICE criteria. Copyright Â
OBJECTIVE: To investigate the impact of the International Association of Diabetic Pregnancy Study Group (IADPSG) diagnostic criteria on the prevalence of gestational diabetes mellitus (GDM) and overt diabetes as compared with the UK National Institute for Health and Care Excellence (NICE) criteria, and to evaluate the prevalence of maternal and perinatal outcomes among pregnant women with fasting plasma glucose (FPG) levels of 5.1-5.5 mmol/L. METHODS: A retrospective study was undertaken of data for women who underwent a 2-hour 75-g oral glucose tolerance test at 24-32 weeks of a singleton pregnancy at a center in Croatia between January 2012 and December 2014. RESULTS: Among 4646 included women, 1074 (23.1%) had GDM according to IADPSG criteria, 826 (17.8%) would be diagnosed according to NICE criteria, and 50 (1.1%) had overt diabetes. FPG levels were 5.1-5.5 mmol/L for 409 (8.8%) women. Compared with a control group (n=3391), these women had higher odds of large-for-gestational-age newborns (odds ratio 3.7, 95% CI 2.0-4.6) and cesarean delivery (odds ratio 1.8, 95% CI 1.3-2.3). CONCLUSION:Women with FPG levels of 5.1-5.5 mmol/L have an increased risk of adverse maternal and perinatal outcome, although they would not be diagnosed with GDM according to NICE criteria. Copyright Â
Authors: Aoife M Egan; Akke Vellinga; Jürgen Harreiter; David Simmons; Gernot Desoye; Rosa Corcoy; Juan M Adelantado; Roland Devlieger; Andre Van Assche; Sander Galjaard; Peter Damm; Elisabeth R Mathiesen; Dorte M Jensen; Liselotte Andersen; Annuziata Lapolla; Maria G Dalfrà; Alessandra Bertolotto; Urszula Mantaj; Ewa Wender-Ozegowska; Agnieszka Zawiejska; David Hill; Judith G M Jelsma; Frank J Snoek; Christof Worda; Dagmar Bancher-Todesca; Mireille N M van Poppel; Alexandra Kautzky-Willer; Fidelma P Dunne Journal: Diabetologia Date: 2017-07-12 Impact factor: 10.122
Authors: Raigam J Martinez-Portilla; Jose R Villafan-Bernal; Diana L Lip-Sosa; Eva Meler; Jordi Clotet; Francisco J Serna-Vela; Sergio Velazquez-Garcia; Leopoldo C Serrano-Diaz; Francesc Figueras Journal: J Diabetes Res Date: 2018-12-30 Impact factor: 4.011